AK129 Combination Therapy for Advanced Solid Tumors

Clinical trial NCT06943820 · RECRUITING

Trial details

NCT number: NCT06943820
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIB/IV Head and Neck Squamous Cell Carcinoma (HNSCC)Colorectal Adenocarcinoma Advanced Solid Tumors

Start date: 2025-05-21
Primary completion: 2026-12-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.